Expression of HSD11K (NAD+ dependent 11beta-hydroxysteroid dehydrogenase) promoter [PMID: 10921454] Laboratory literature summary: Expression of HSD11K (NAD+ dependent 11beta-hydroxysteroid dehydrogenase) promoter constructs in renal cell lines
Amgen, the pharmaceutical company that produces Enbrel in the United States, still has patent protection over the drug, meaning other companies cannot yet make biosimilar versions of the medication that tend to be less expensive. There is no Enbrel biosimilar (comparable to a generic) yet
it does not actively kill all microbes (that would be bactericidal), but it stops them from reproducing, which is sufficient to maintain sterility in a closed multi-dose vial
HPLC purity around 99% or higher, backed by mass spectrometry that confirms identity
This combo blends dexpanthenol + the Triple Burner shot: vitamin B12 formulated with methionine*, inositol, choline for hormone + emotional balance, fat reduction, blood sugar control + cholesterol management